semaglutide to wegovy conversion Dosing Schedule Switching between weight-loss medications -

Saxenda is approved for: Adults Adults with obesity (BMI of 30 kg/m or greater) Adults who are overweight (BMI of 27 kg/m or greater) and have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol Children aged 12 and older Adolescents with obesity who weigh more than 60 kg (132 pounds) Limitations of use Saxenda should not be used together with other medicines that contain liraglutide, such as Victoza, or with any other GLP-1 receptor agonist, such as Ozempic, Wegovy, or Trulicity The safety and effectiveness of Saxenda in children aged 12 to 17 years who have type 2 diabetes have not been established

Domestic telehealth programs provide a safer, more consistent way to access GLP-1 therapy with professional medical oversight

In 2023, about 5 million Americans used GLP-1 medications

Will my insurance cover my medication

XOR, Xanthine oxidoreductase